Medication prescriptions are at the discretion of the evaluating medical provider, not the platform
GLP-1 (Glucagon-like Peptide-1) is a hormone produced in the small intestine that helps regulate blood sugar levels by: Enhancing insulin secretion Suppressing glucagon release Slowing gastric emptying Reducing appetite What makes GLP-1 agonists especially promising is their broad distribution of receptors throughout the body, including in the brain, heart, kidneys, lungs, skin, and gastrointestinal tractindicating potential systemic effects that go well beyond glucose control
It is focused in part on something called GHK-Cu
The liver uses the glutathione to detoxify and remove toxins from the body
On portfolio, companies should candidly assess which products face structural headwinds and which are positioned to benefit
The only definitive method is HPLC (high-performance liquid chromatography) analysis, which most researchers dont have access to